1
Participants
Start Date
August 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
MMSE
Neurocognitive function via MMSE done every 3 months for length of study.
QOL via FACT-Br
Quality of Life via FACT-BR every 3 months for length of study.
MRI
MRI done every 3 months for the length of the study.
Post-operative SRS
Single fraction SRS is currently a viable treatment option of intracranial metastatic lesions.
Duke Comprehensive Cancer Center, Durham
Lead Sponsor
National Cancer Institute (NCI)
NIH
Duke University
OTHER